FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Birchview Capital, LP		 2. Date of Event Requiring Statement (MM/DD/YYYY)
12/5/2021 

 3. Issuer Name and Ticker or Trading Symbol

AZIYO BIOLOGICS, INC. [AZYO]
(Last)        (First)        (Middle)

688 PINE STREET, SUITE D		 4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                          ___X___ 10% Owner
_____ Officer (give title below)        _____ Other (specify below)
(Street)

BURLINGTON, VT 05401      

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed(MM/DD/YYYY)
 

6. Individual or Joint/Group Filing(Check Applicable Line)

___ Form filed by One Reporting Person
_X_ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)		2. Amount of Securities Beneficially Owned
(Instr. 4)		3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)		4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Class A Common Stock 1417923 I See footnotes (1)(2)(3)(4)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)		2. Date Exercisable and Expiration Date
(MM/DD/YYYY)		3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)		4. Conversion or Exercise Price of Derivative Security5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)		6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
(1) Matthew Strobeck is the Managing Member of Birchview Capital GP, LLC, who is the General Partner of Birchview Capital, LP. Matthew Strobeck is the Managing Member of Birchview Partners LLC, who is the Manager of Birchview Fund, LLC ("the Fund"). Birchview Capital, LP is the investment manager of Birchview Fund, LLC.
(2) Birchview Fund, LLC acquired 1,134,905 of the shares. Matthew Strobeck personally acquired 165,094 of the shares and acquired an additional 117,924 of the shares in custodial accounts in his name (the "Strobeck Shares").
(3) Of the Strobeck Shares, all 283,018 of the Strobeck Shares were held in separately managed accounts ("SMA") for which Birchview Capital, LP provided investment advice.
(4) As the investment manager of the Fund, Birchview Capital, LP possesses the power to vote and dispose or direct the disposition of all the 1,134,905 shares held by the Fund.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
Birchview Capital, LP
688 PINE STREET, SUITE D
BURLINGTON, VT 05401
X

Birchview Fund LLC
688 PINE STREET, SUITE D
BURLINGTON, VT 05401
X

Strobeck Matthew
688 PINE STREET, SUITE D
BURLINGTON, VT 05401
X
Signatures
Birchview Capital, LP By: /s/ Matthew Strobeck Matthew Strobeck, Managing Member of Birchview Capital GP, LLC, General Partner of Birchview Capital, LP2/13/2023
**Signature of Reporting PersonDate

Birchview Fund LLC By: /s/ Matthew Strobeck Matthew Strobeck, Managing Member of Birchview Partners LLC, Manager of Birchview Fund LLC2/13/2023
**Signature of Reporting PersonDate

/s/ Matthew Strobeck Matthew Strobeck2/13/2023
**Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Aziyo Biologics (NASDAQ:AZYO)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Aziyo Biologics Charts.
Aziyo Biologics (NASDAQ:AZYO)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Aziyo Biologics Charts.